BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37849611)

  • 21. Large facial lymphatic malformation treatment using sclerosing agent followed by surgical resection: clinical and pathology report.
    Laviv A; Maly A; Abu-Tair J
    Oral Maxillofac Surg; 2017 Sep; 21(3):363-369. PubMed ID: 28735345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
    Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital Venolymphatic Malformation Treated With Sodium Tetradecyl Sulfate: A Case Report.
    Das S; Agrawal A; Burathoki SK; Nandolia KK; Juneja A; Samanta R
    Cureus; 2022 Sep; 14(9):e29173. PubMed ID: 36259024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
    Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
    J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerotherapy followed by surgery for the treatment of oral hemangioma: a report of two cases.
    Mariano FV; Vargas PA; Della Coletta R; Lopes MA
    Gen Dent; 2011; 59(3):e121-5. PubMed ID: 21903533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.
    Park HS; Do YS; Park KB; Kim KH; Woo SY; Jung SH; Kim DI; Kim YW; Hyun D; Cho SK; Choo IW
    Eur Radiol; 2016 May; 26(5):1301-10. PubMed ID: 26307182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases.
    Krokidis M; Venetucci P; Hatzidakis A; Iaccarino V
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S228-31. PubMed ID: 20559638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined surgery and sclerotherapy for massive venous malformations of the tongue].
    Huang X; Zou H; Guo X; Zhao Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jan; 32(1):14-7. PubMed ID: 27197473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerotherapy of craniofacial venous malformations: complications and results.
    Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
    Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment for telangiectasias and reticular veins.
    Nakano LC; Cacione DG; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012723. PubMed ID: 34637138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and Safety of Sclerotherapy for Treatment of Low-Flow Vascular Malformations of the Oropharyngeal Region.
    Bourgouin P; Thomas-Chaussé F; Gilbert P; Giroux MF; Périgny S; Guertin L; Dubois J; Soulez G
    J Vasc Interv Radiol; 2018 Jun; 29(6):809-815. PubMed ID: 29628299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sclerotherapy for intramuscular vascular malformations: A single-center experience.
    Scorletti F; Patel MN; Hammill AM; Ricci KW; Myer CM; Dasgupta R
    J Pediatr Surg; 2018 May; 53(5):1056-1059. PubMed ID: 29519571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
    Lidsky ME; Markovic JN; Miller MJ; Shortell CK
    J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staged endovascular and surgical treatment of slow-flow vulvar venous malformations.
    Nassiri N; O TM; Rosen RJ; Moritz J; Waner M
    Am J Obstet Gynecol; 2013 May; 208(5):366.e1-6. PubMed ID: 23395642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 6-year experience treating vascular malformations with foam sclerotherapy.
    Markovic JN; Kim CY; Lidsky ME; Shortell CK
    Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and network meta-analysis of the effectiveness of sclerotherapy for venous malformation.
    Cao J; Liu J; Zhang X; Wang Z
    J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):210-218.e3. PubMed ID: 36179784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of sonographically guided percutaneous sodium tetradecyl sulfate injection with ethanol injection in the treatment of benign nonfunctioning thyroid nodules.
    Kalra N; Ahuja CK; Dutta P; Rajwanshi A; Mittal BR; Bhansali A; Khandelwal N
    J Vasc Interv Radiol; 2014 Aug; 25(8):1218-24. PubMed ID: 24954607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of sclerotherapy for treatment of vascular malformation in a young girl.
    Kalyankar R; Mardikar M; Kothekar S; Mardikar HM; Deshpande NV
    J Assoc Physicians India; 2014 Oct; 62(10):60-3. PubMed ID: 25906527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions.
    Bajpai H; Bajpai S
    J Maxillofac Oral Surg; 2012 Mar; 11(1):13-20. PubMed ID: 23449774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of 0.5% Sodium Tetradecyl Sulfate on a Venous Lake Lesion.
    Jung SJ; Seo YJ; Park EJ; Kim CW; Cho HJ; Kim KH; Kim KJ
    Ann Dermatol; 2008 Dec; 20(4):179-83. PubMed ID: 27303187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.